Skip to main content
. 2022 Apr 6;10(10):3047–3059. doi: 10.12998/wjcc.v10.i10.3047

Table 3.

The computed tomography score of the pulmonary involvement in four stages


Stage-1 (n = 157)
Stage-2 (n = 194)
Stage-3 (n = 165)
Stage-4 (n = 211)
Stage-5 (n = 204)
Stage-6 (n = 137)
P value
Total CT score of the pulmonary involvement 2 ± 4 (0-18) 5 ± 5 (0-22) 7 ± 7 (0-22) 7 ± 7 (0-25) 5 ± 7 (0-24) 4 ± 6 (0-25) < 0.00011
Number of involved lobes 22 ± 2 (0-5) 3 ± 2 (1-5) 4 ± 2 (1-5) 3 ± 2 (1-5) 3 ± 2 (1-5) 4 ± 2 (1-5) < 0.00011
CT score in each lobe < 0.00011
Left upper lobe 0 ± 1 (0-3) 1 ± 2 (0-5) 1 ± 2 (0-5) 1 ± 2 (0-5) 1 ± 2 (0-4) 1 ± 1 (0-5)
Left lower lobe 1 ± 1 (0-5) 1 ± 2 (0-5) 2 ± 2 (0-5) 2 ± 1 (0-5) 1 ± 2 (0-5) 1 ± 2 (0-5)
Right upper lobe 0 ± 1 (0-3) 1 ± 2 (0-5) 1 ± 2 (0-5) 1 ± 2 (0-5) 1 ± 2 (0-5) 1 ± 2 (0-5)
Right middle lobe 0 ± 1 (0-3) 1 ± 1 (0-5) 1 ± 2 (0-5) 1 ± 2 (0-5) 1 ± 1 (0-5) 0 ± 1 (0-5)
Right lower lobe 1 ± 2 (0-12) 2 ± 1 (0-5) 2 ± 2 (0-5) 1 ± 2 (0-5) 1 ± 1 (0-5) 1 ± 1 (0-5)

Quantitative data were presented as mean ± SD (minimum-maximum). Mann-Whitney U test showed significant difference between Stage-1 and Stage-2-6 (P < 0.05); Wilcoxon test showed significant difference between the left lower lobe and the left upper lobe (P < 0.05); Wilcoxon test showed significant difference between the right lower lobe and the right upper/middle lobe (P < 0.05).

1

P < 0.05 by t test.

CT: Computed tomography.